Perceived differences between intensivists and infectious diseases consultants facing antimicrobial resistance: a global cross-sectional survey
Perceived differences between intensivists and infectious diseases consultants facing antimicrobial resistance: a global cross-sectional survey
复制标题
DOI：
10.1007/s10096-019-03530-1
复制
发表时间：
2019-07-01
影响因子：
4.5
通讯作者：
Von der Osten, J.
中科院分区：
文献类型：
--
作者：
Rello, Jordi;Eshwara, Vandana Kalwaje;Von der Osten, J.
确定对多重耐药（MDR）微生物及其在重症监护室（ICU）管理的认知差异。进行了横断面调查。将TOTEM研究中提出的ICU病原体优先列表（PPL）提案与危重患者感染方面的全球专家样本进行比较。129名专家对调查作出了答复。在全球范围内，ESBL肠杆菌科，其次是碳青霉烯类耐药鲍曼不动杆菌和碳青霉烯类耐药肺炎克雷伯菌，是主要的问题。在63名（49%）ICU医生（ICU/麻醉学）和43名（33%）传染病顾问（ID医生/微生物学家）之间发现了一些意见差异。重症监护病房最关注的病原体是ESBL肠杆菌科（38%）和碳青霉烯类耐药A。鲍曼不动杆菌（48.3%），（p
To identify differences in perception on multi-drug-resistant (MDR) organisms and their management at intensive care units (ICU). A cross-sectional survey was conducted. A proposal addressing a pathogen priority list (PPL) for ICU, arising from the TOTEM study, was compared with a sample of global experts in infections in critically ill patients. The survey was responded by 129 experts. Globally, ESBL Enterobacteriaceae, followed by carbapenem-resistant Acinetobacter baumannii and carbapenem-resistant Klebsiella pneumoniae, were the main concerns. Some differences in opinion were identified between 63 (49%) ICU physicians (ICU/anesthesiology) and 43 (33%) infectious disease consultants (ID physicians/microbiologists). The pathogens most concerning in the ICU for intensivists were ESBL Enterobacteriaceae (38%) versus carbapenem-resistant A. baumannii (48.3%) for ID consultants, (p